Living forwards or understanding backwards? A comparison of Inverse Probability of Treatment Weighting and G-estimation methods for targeting hypothetical full adherence estimands in longitudinal cohort studies

Xiaoran Liang, Deniz Türkmen, Jane A H Masoli, Luke C Pilling, Jack Bowden · 2026

Read Living forwards or understanding backwards? A comparison of Inverse Probability of Treatment Weighting and G-estimation methods for targeting hypothetical full adherence estimands in longitudinal cohort studies by Xiaoran Liang, Deniz Türkmen, Jane A H Masoli, Luke C Pilling, Jack Bowden (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-06916.txt.

Introduction

Liang and colleagues compare two causal methods for a what-if full adherence target in cohort studies. Taking medicine as ordered matters, yet non-adherence often spoils results, so they model time-varying effects of steady adherence on health with observational data. IPTW and G-estimation both handle time-varying mixing under a no unmeasured confounding assumption. They adapt both methods to real-world settings and show them. Trial uses cover non-adherence as an intercurrent event; instrumental extensions of G-estimation apply when the assumption may fail.

Catalog record

CREATORXiaoran Liang, Deniz Türkmen, Jane A H Masoli, Luke C Pilling, Jack Bowden
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67965
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2603.06916

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Living forwards or understanding backwards? A comparison of Inverse Probability of Treatment Weighting and G-estimation methods for targeting hypothetical full adherence estimands in longitudinal cohort studies Xiaoran Liang, Deniz Türkmen, Jane A H Masoli, Luke C Pilling, Jack Bowden Abstract Medication adherence is essential to ensure treatment effectiveness, but too often in routine care non-adherence compromises the desired outcome. We explore longitudinal causal modelling using observational data to estimate the time-varying effects of continuous drug adherence measures on health outcomes over a sustained period. The goal of such analyses is to quantify the potential impact of interventions to improve adherence on long-term health. We consider two established longitudinal causal approaches designed to handle time-varying confounding under the “no unmeasured confounding” (NUC) assumption: G-estimation and inverse probability of treatment weighting (IPTW). In randomized trials, NUC-based methods have been applied to address non-adherence as an intercurrent event, and instrumental variable (IV) extensions of G-estimation have also been introduced for settings where the NUC assumption may fail. We adapt these methods to observational data settings and illustrate their use for assessing how adherence over time impacts health outcomes. We align the causal parameters across methods and show they can target the same causal estimand: the average effect among treated individuals of full adherence versus zero adherence. We set out the identification conditions for IPTW and G-estimation under NUC, and for an IV-based extension that has specific utility when the NUC assumption is implausible. We assess the statistical properties, strengths and weaknesses of each approach through Monte Carlo simulations designed to reflect longitudinal studies with a continuous exposure. We demonstrate these methods by quantifying the effect of full statin adherence on LDL cholesterol control in 13,000 UK Biobank participants with linked primary care data. Keywords : Longitudinal causal modeling; G-estimation; Inverse Probability of Treatment Weighting; Instrumental Variables; Time-varying confounding; Drug adherence; Statin therapy; Pharmacogenetics. 01-Introduction 1 Methods 1.1 Longitudinal Modelling Framework and the Causal Estimand of Interest Suppose we have a sample of n on-medication patients followed longitudinally across K time points. For each individual i and time point k ( k\in\{1,...,K\} ), we assume complete information on the following variables is available in theory: • Drug adherence status A_{i,k} . • A continuous clinical outcome measure Y_{i,k} . • An l\times 1 vector \bm{L}_{i,k} which includes all l observed covariates (both baseline and time-varying) at time point k that confound the A-Y relationship. Additionally, to formalize the potential for confounding, we posit the existence of: • An ‘unobserved’ confounder U_{i,k} between A_{i,k} and Y_{i,k} . The longitudinal data structure is illustrated in Figure 1 with three time points. In this setting, adherence at a given time may affect later outcomes both directly and indirectly through mediators (such as through its influence on intermediate outcomes). When we refer to the “effect of adherence at time j on outcome at time k ” ( j\leq k ), we mean the total effect that operates along all pathways except those that pass through future adherence status. The arrows in Figure 1 use different colours to highlight the components of the total causal effect of adherence at each time point on the longitudinal outcomes: red for A_{1} , blue for A_{2} and green for A_{3} . Let the vector \bar{\bm{A}}_{i,k} denote the adherence history of individual i up to time point k , so that \bar{\bm{A}}_{i,k}=\left(A_{i,1},...,A_{i,k}\right) . Define Y_{i,k}(\bar{\bm{a}}_{k}) as the potential outcome at time point k given that the adherence history took, possibly contrary to fact, the value \bar{\bm{a}}_{k} . We are interested in quantifying the difference between mean potential outcomes under different intervention histories in order to inform future policy decisions and, more broadly, to compare different statistical approaches for estimating them from observational data. In principle, we can consider contrasts between any two adherence histories \bar{\bm{a}}_{k} and \bar{\bm{a}}_{k}^{\prime} . In this paper our primary focus is the comparison between sustained full adherence and sustained non-adherence, represented by the constant histories \bar{\bm{a}}_{k}=\mathbf{1}_{k} (full adherence at every time up to k ) and \bar{\bm{a}}_{k}^{\prime}=\mathbf{0}_{k} (no adherence at any time up to k ), respectively. Our primary estimand of interest is therefore the difference in mean potential outcomes among the medication initiators: \mathbb{E}[Y_{i,k}(\bm{1}_{k})-Y_{i,k}(\bm{0}_{k})\mid S=1]\text{ for $k=1,...,K$}. (1) In Equation (1), S=1 denotes that we are conditioning on being treated with the chosen medication (e.g., statin), and the target estimand is defined among those prescribed the medication. For brevity, we implicitly assume and therefore omit this conditioning from now on in subsequent expressions. For the remainder of the methodology sections, we anchor our theoretical development to an arbitrary target time point k . To simplify notation, we drop the subscript k and denote this target outcome simply as Y (i.e., Y\equiv Y_{i,k} ), with the understanding that the framework applies identically to any chosen time horizon k\in\{1,\dots,K\} . Throughout, we also suppress the individual patient subscript i for notational convenience. \bm{L}_{1},U_{1} \bm{L}_{2},U_{2} \bm{L}_{3},U_{3} A_{1} A_{2} A_{3} Y_{1} Y_{2} Y_{3} Figure 1 : Illustration of the assumed longitudinal causal structure with three time points. Arrows are colour-coded to reflect the components of the total causal effect of adherence at each time point: red for A_{1} , blue for A_{2} and green for A_{3} . For visual clarity, we omit some arrows (such as the direct effect of A_{1} on \bm{L}_{3} ), but the framework allows for general relationships where variables may depend on the entire past history. 1.2 Parameterizing the Causal Estimand via MSM and SNMM To estimate the causal contrast defined in Equation ( 1 ), we link potential outcomes to observed data using two modelling frameworks commonly used for longitudinal causal inference: SNMM and MSM [ 98 , 86 , 102 ] . We begin with the SNMM which models the causal effect of adherence at each time point through the blip function. We define patients’ observed history \bm{H}_{j} as the collection of all information available up to time j : \bm{H}_{j}=(\bar{\bm{A}}_{j-1},\bar{\bm{Y}}_{j-1},\bar{\bm{L}}_{j}) for j=1,\dots,k . Here, \bar{\bm{L}}_{j} denotes the observed covariate history up to time j , and \bar{\bm{Y}}_{j-1} denotes the observed intermediate outcome history up to time j-1 . The blip at time j is defined as the contrast in conditional mean potential outcomes when adherence at time j is set to a_{j} versus set to 0 , given the observed history \bm{H}_{j} , holding the past adherence fixed and setting the future adherence as 0 [ 98 , 140 ] : \mathbb{E}[Y(\bar{\bm{a}}_{j-1},a_{j},\bm{0}_{k-j})-Y(\bar{\bm{a}}_{j-1},0,\bm{0}_{k-j})\mid\bm{H}_{j},A_{j}=a_{j}]=\psi_{j}(a_{j},\bm{H}_{j}). (2) It is a conditional causal effect that compares switching on/off adherence at time j among individuals with the same observed history \bm{H}_{j} . Here we assume no effect modification by exposure, outcome and covariate histories, and let the blip function depend only on the current adherence level a_{j} . Additionally, we assume “no current treatment interaction” (NCTI), which states that the causal effect is invariant to the actual adherence status A_{j} . Following the notation in [ 139 ] , we formalize the NCTI assumption as: \displaystyle\mathbb{E}[Y(\bar{\bm{a}}_{j-1},a_{j},\bm{0}_{k-j})-Y(\bar{\bm{a}}_{j-1},0,\bm{0}_{k-j})\mid\bm{H}_{j},A_{j}=a^{\prime}] \displaystyle=\mathbb{E}[Y(\bar{\bm{a}}_{j-1},a_{j},\bm{0}_{k-j})-Y(\bar{\bm{a}}_{j-1},0,\bm{0}_{k-j})\mid\bm{H}_{j},A_{j}=a^{\prime\prime}]\quad\forall a^{\prime},a^{\prime\prime}. Collectively, under these structural assumptions, the blip function simplifies to the following form: \psi_{j}(a_{j},\bm{H}_{j})=\beta_{j}a_{j}\quad\text{ for all $\bm{H}_{j}$}. (3) In Appendix A.1, we show that under the linear blip specification in Equation ( 3 ), the estimand in Equation ( 1 ) can be

Read the complete text